Related Experiment Video
Updated: Apr 15, 2026

07:32
Author Spotlight: 3D Movement Assessment of Maxillary Posterior Teeth in Clear Aligner Treatment
Published on: February 23, 2024
2.1K
Addressing missing participant outcome data in dental clinical trials
Loukia M Spineli1, Padhraig S Fleming2, Nikolaos Pandis3
1Institut für Biometrie, Medizinische Hochschule Hannover, Hannover, Germany.
Journal of Dentistry
|April 4, 2015
Summary
Missing outcome data in clinical trials can cause bias. Intention-to-treat (ITT) analysis, with proper data imputation, is preferred over per-protocol (PP) analysis for credible trial findings.
Area of Science:
- Clinical Trials
- Biostatistics
- Health Research Methodology
Background:
- Missing outcome data is a frequent challenge in clinical trials, even with robust protocols.
- Participant attrition and exclusion post-randomization lead to information loss, potentially introducing attrition bias and complicating result interpretation.
- The mechanisms of missingness can significantly impact the reliability and credibility of clinical trial findings.
Purpose of the Study:
- To highlight key issues surrounding missing outcome data in clinical trials.
- To describe recognized methods for handling missing data.
- To explain the principles of intention-to-treat (ITT) and per-protocol (PP) analyses.
Main Methods:
- Utilized a worked example from a published dental study.
- Discussed common causes and implications of missing data.
- Reviewed established approaches for managing missing outcome data.
- Explained the theoretical underpinnings of ITT and PP analysis.
Main Results:
- Identified attrition bias as a significant consequence of missing data.
- Emphasized that the 'mechanism of missingness' affects result credibility.
- Demonstrated the importance of appropriate assumptions and imputation for true ITT analysis.
Conclusions:
- Handling missing outcome data appropriately is crucial for valid clinical trial interpretation.
- Intention-to-treat (ITT) analysis is generally recommended over per-protocol (PP) analysis when dealing with missing data.
- Effective management of missing data, including imputation, is essential for maintaining the integrity of trial results.
Related Concept Videos
Clinical Trials: Overview
5.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.5K
Clinical Trials
11.2K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
11.2K
